Litcius/Paper detail

Preliminary Study of the Protectiveness of Vaccination Against the COVID-19 in the Outbreak of VOC Omicron BA.2 - Jilin City, Jilin Province, China, March 3-April 12, 2022.

Xuebin Fan, Shan Lü, Lu Bai, Haican Liu, Junshao Fu, Xiaoxun Jin, Yulong He, Jinxing Lu, Xiaoping Dong

2022PubMed15 citationsDOIOpen Access PDF

Abstract

What is already known about this topic?: An outbreak of coronavirus disease 2019 (COVID-19) of Omicron BA.2 emerged in Jilin City since March 3, 2022, which involved in 27,036 cases by April 12. The vaccination program with inactivated COVID-19 vaccines has been implemented since the beginning of 2021. What is added by this report?: The incidences of moderate, severe, and critical cases in the whole population of the group of 0+1 dose were 1.82-, 9.49-, and 3.85-fold higher than those in the group of 2 doses, and 5.03-, 44.47-, and ∞-fold higher than those received 3 doses vaccination. For the population ≥60 years, the incidences of moderate, severe, and critical cases in the group of 0+1 dose were 29.92, 9.62, and 4.27 per 100,000, showing 4.13-, 43.72-, and 4.85-fold higher than 2 doses, as well as 13.28-, 22.37-, and ∞-fold higher than 3 doses. What are the implications for public health practice?: The incidences of each type of COVID-19 in the population who were fully vaccinated or booster vaccinated in Jilin City were significantly lower than those who were unvaccinated and/or partially vaccinated. Booster vaccination with homologous inactivated vaccines induces stronger protectiveness for COVID-19 caused by variant of concern (VOC) Omicron.

Topics & Concepts

OutbreakVaccinationCoronavirus disease 2019 (COVID-19)Booster (rocketry)MedicinePopulationBooster doseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyEnvironmental healthTiterDiseaseInfectious disease (medical specialty)Internal medicineVirusPhysicsAstronomySARS-CoV-2 and COVID-19 ResearchRespiratory viral infections researchCOVID-19 Clinical Research Studies